Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.26M | -6.84M | -5.37M | -5.48M | -5.65M |
| Total Depreciation and Amortization | 715.60K | 725.40K | 731.10K | 744.90K | 763.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.17M | 1.07M | 956.80K | 1.11M | 1.25M |
| Change in Net Operating Assets | -921.60K | -921.60K | -921.60K | -1.07M | -1.23M |
| Cash from Operations | -7.29M | -5.96M | -4.60M | -4.70M | -4.87M |
| Capital Expenditure | -73.20K | -66.00K | -58.50K | -84.50K | -111.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 3.30K | 6.70K |
| Cash from Investing | -73.20K | -66.00K | -58.50K | -81.20K | -105.10K |
| Total Debt Issued | 886.00K | 886.00K | 886.00K | 961.50K | 1.04M |
| Total Debt Repaid | -1.54M | -3.59M | -5.63M | -5.70M | -5.76M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -433.20K | -1.77M | -3.10M | -3.09M | -3.07M |
| Foreign Exchange rate Adjustments | -11.90K | -8.30K | -4.70K | 32.00K | 69.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.81M | -7.80M | -7.77M | -7.83M | -7.98M |